Syringe exchange program played key role in controlling HIV outbreak

June 14, 2018, Indiana University
Credit: CC0 Public Domain

A study by researchers investigating the 2015 HIV outbreak in Scott County, Indiana, found that a syringe services program is an important tool to control and prevent HIV outbreaks among people who inject drugs in a nonurban area.

Researchers said the program resulted in a rapid reduction in injection-related risk behaviors, including an 88 percent reduction in sharing, a 79 percent reduction in syringe sharing to divide drugs and an 81 percent reduction in sharing of other injection equipment.

There were 181 HIV infections diagnosed between Nov. 18, 2014, and Nov. 1, 2015, in Scott County, making it the largest HIV outbreak in a nonurban area in the U.S. among people who inject drugs.

The syringe services program was initially implemented on an emergency basis to combat the outbreak. It was the first time such a program had been tried in a nonurban area in the United States. Syringe services programs provide clients with sterile syringes along with prevention, education and social services.

Researchers discovered the HIV outbreak was linked to injection of Opana ER, an opioid pain medication. The research elicited specific characteristics of the drug which, when dissolved, resulted in multiple injection episodes per day and multiple injections per injection episode, and prompted officials from Indiana and the Centers for Disease Control, working with the U.S. Food and Drug Administration, to request that the drug's manufacturer voluntarily remove the drug from the U.S. market.

A paper with the researchers' findings, "Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe-Services Program During an HIV Outbreak," was recently published in the Journal of Acquired Immune Deficiency Syndrome.

At the outset of the study, researchers knew what had happened, but not why.

"An outbreak doesn't just happen in the HIV world," said Carrie Foote, an associate professor of sociology in the School of Liberal Arts at IUPUI and the co-principal investigator of the study's qualitative data.

Researchers gathered two kinds of data, quantitative and qualitative, a move they believe enhanced their ability to understand what had happened in Scott County.

Qualitative data was gathered from focus groups and one-on-one interviews with people who were injecting drugs in Scott County. Quantitative data came from answers by clients of the syringe services program to a set of questions asked of each person who took advantage of the program.

"If we just had the quantitative data, we wouldn't have been able to dive into the unique injection practices around Opana ER, which we believe led to this outbreak of HIV," said Dr. Joan Duwve, an associate professor and associate dean of public health practice in the Richard M. Fairbanks School of Public Health at IUPUI and the lead investigator of a quantitative study further exploring the risks of acquiring HIV infection in this population.

Because a single 40-milligram pill costs about $160, drug users formed networks to pool their resources to buy Opana ER, she said. Multiple people would share syringes, or reuse old syringes to draw up the dissolved pill. More water was then added to rinse the pill residue off of the cooker. Reusing the same needles, rinse solution was drawn up and injected or saved to use later.

Without access to sterile syringes, people in the networks frequently shared syringes as they injected multiple times a day. One individual told the researchers he injected 50 times a day. Others described how one syringe was used over and over again until it broke off in someone's arm.

"It's no wonder that as soon as someone who had HIV entered into that network, HIV spread rapidly," Foote said.

"It was incredibly powerful to see how much the syringe exchange program mattered," Foote said. "They matter in all communities, but it made such a powerful difference in this particular community in terms of reducing the harm that comes from sharing syringes for multiple injections."

Exploring harm-reduction measures like syringe exchange programs is part of Indiana University's Responding to the Addictions Crisis Grand Challenge, which brings together IU's world-class faculty and its business, nonprofit and government partners to create a comprehensive plan to reduce deaths from addiction, ease the burden of addiction on Hoosier communities, and improve health and economic outcomes. As part of IU's Grand Challenges program, this collaborative, statewide initiative is the nation's largest and most comprehensive university-led response to the opioid addiction crisis.

Explore further: Harm reduction services less available in areas plagued by rising IV drug use and HIV infections

More information: Monita R. Patel et al. Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak, JAIDS Journal of Acquired Immune Deficiency Syndromes (2017). DOI: 10.1097/QAI.0000000000001615

Related Stories

Harm reduction services less available in areas plagued by rising IV drug use and HIV infections

December 10, 2015
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn ...

Use of needle exchange programs up dramatically in 10 years: CDC

November 30, 2016
(HealthDay)—Although there was a significant increase in the use of syringe services programs (SSPs)—more commonly known as needle exchange programs—across the United States over the past decade, many injection drug ...

Rapid HIV transmission seen in injection drug users in rural U.S.

July 22, 2016
(HealthDay)—The U.S. prescription drug abuse epidemic has increased the risk of HIV outbreaks in rural and suburban communities, where up to now the virus has posed little threat, according to a report published in the ...

Drug epidemic stalls HIV decline in whites who shoot up

November 29, 2016
The long decline in HIV infections among white people who inject drugs has stalled, another grim side effect of the nation's drug abuse epidemic.

In a city ravaged by heroin, a needle exchange stalls

October 31, 2017
As she pressed down on the plunger of an empty syringe, a drop of blood oozed from the crooked tip of its needle—a test, Denise Brown said, that she uses on unpackaged syringes she now buys on the street.

Hit hard by opioid crisis, Appalachian states expand clean-needle programs

May 11, 2018
(HealthDay)—In 2013, there was just one clean-needle program in all of West Virginia, Kentucky and North Carolina, and the latter two states had laws banning such programs.

Recommended for you

Long-acting injectable implant shows promise for HIV treatment and prevention

October 9, 2018
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results.

Scientists develop rapid test for diagnosing tuberculosis in people with HIV

October 8, 2018
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected ...

Researchers uncover new role of TIP60 protein in controlling tumour formation

October 8, 2018
Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered a new molecular pathway that controls colorectal cancer development, and their exciting ...

Combination therapy targets latent reservoir of HIV

October 3, 2018
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

Anti-integrin therapy effect on intestinal immune system in HIV-infected patients

October 3, 2018
In a study published today in Science Translational Medicine, Mount Sinai researchers describe for the first time a mechanism that may shrink collections of immune cells in the gastrointestinal (GI) tract, called lymphoid ...

No 'reservoir': Detectable HIV-1 in treated human liver cells found to be inert

October 1, 2018
In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.